Heart and Blood Diseases

All Conditions

Nutritional and Metabolic Diseases

Substance Related Disorders

Symptoms and General Pathology

Wounds and Injuries

Heart Failure

Vascular Diseases

Metabolic Diseases

Heart Diseases

Drug-Related Side Effects and Adverse Reactions

Cardiotoxicity

Chemically-Induced Disorders

Radiation Injuries

Drugs and treatments used in cancer inducing cardiovascular and metabolic side effects

Anti-Cancer Agents

Joe-Elie Salem, MD, PhD

Stéphane Edehry, MD

Edehry Stephane, MD

Joe-Elie Salem, Md, PhD

Several Drugs used in routine care in oncology induce rare but often severe or fatal cardiovascular or metabolic side effects. This study will investigate, evaluate, report and treat the cardiovascular side effects of anticancer drugs, through a specific cardiovascular routine checkup and follow-up taking place in several Cardio-oncology programs throughout France. The different including centers will be: Assistance Publique - Hôpitaux de Paris (APHP.6: Pitié-Salpétrière, Saint Antoine and Tenon's hospitals, Paris, France).

Several anticancer and supportive care drugs used in oncology have an impact on the cardiovascular and metabolic systems, leading to a wide range of cardiovascular and metabolic disorders and side effects. Those are poorly described, due to the evolution of the anticancer pharmacopeia, and recent recognition of these adverse events. This study will investigate the potential benefits of a specialized cardio-oncology check-up and follow-up in this context.

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

Groupe Hospitalier Pitie-Salpetriere

Assistant director, clinical investigation center Paris Est

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care	NCT03882580	Cardiovascular ... Cardiovascular ... Cardiac Complic... Oncologic Compl... Cardiac Insuffi... Metabolic Disor... Vascular Disord... Cardiac Disorde...	Anti-Cancer Age...	18 Years -	Groupe Hospitalier Pitie-Salpetriere
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care	NCT03882580	Cardiovascular ... Cardiovascular ... Cardiac Complic... Oncologic Compl... Cardiac Insuffi... Metabolic Disor... Vascular Disord... Cardiac Disorde...	Anti-Cancer Age...	18 Years -	Groupe Hospitalier Pitie-Salpetriere

Spots Global Cancer Trial Database for cardiovascular insufficiency